Skip to Main Content

Nicholas Hall Group of Companies: Interview with Baker Donelson's Chuck Jolly


Charles N. "Chuck" Jolly, chair of Baker Donelson's Food and Drug Group, participated in the 2018 Nicholas Hall OTC Conference. Chuck concentrates his practice in FDA regulation and in transactions involving products and companies subject to FDA regulation.

"We are in an era where change is taking place every day and it is very clear that the survivors in this environment will be those who can adapt to the change, meet the challenge, understand the new technology and tools that are becoming available and make best use of all those strategies," said Jolly.

Baker Donelson's Food and Drug Group has broad experience navigating the complexities of the FDA through advising established and emerging manufacturers, processors, marketers and other supply chain contributors of foods, prescription and OTC drugs, biologics, medical devices, dietary supplements, cosmetic and personal care products, medical foods and combination products.

Founded in 1978, Nicholas Hall Group of Companies is an international specialist in OTC consumer healthcare and associated industries. They have a wide network of contacts that provide data and analysis, competitive intelligence and strategic advice on a truly global basis.

Related Professionals

Related Practice

Email Disclaimer

NOTICE: The mailing of this email is not intended to create, and receipt of it does not constitute an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.
Cancel Accept